Companies / Lyra Therapeutics, Inc. / Activity
Activity — Lyra Therapeutics, Inc.
5 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Palasis Maria Executive | Sell | Common Stock | $5.7K | -2K -0.15% | 1,096,733 61.79% of shares | low |
| Jan 6, 2026 | Cavalier Jason Executive | Sell | Common Stock | $2.6K | -769 -0.15% | 518,547 29.22% of shares | low |
| Apr 1, 2026 | Palasis Maria Executive | Other | Common Stock | $0 | -2K -0.18% | 1,094,733 61.68% of shares | low |
| Apr 1, 2026 | Cavalier Jason Executive | Other | Common Stock | $0 | -667 -0.13% | 517,880 29.18% of shares | low |
| May 14, 2026 | Smith W Bradford Director | Other | Common Stock | $0 | -640 -100.00% | 0 0.00% of shares | low |